TTM
$6.76B
YoY change
+6.4%
5Y CAGR
+6.0%
Peak year (2025)
$6.52B
Cumulative revenue
$80.95B
Revenue history chart for CME Group (CME) from 2000 to 2025
Latest: $6.52B
Revenue growth chart for CME Group (CME) from 2000 to 2025
Latest: +6.4%
Revenue history table for CME Group (CME) from 2000 to 2025
| 2025 | $6.52B | +6.4% | +$390.50M | ||
| 2024 | $6.13B | +9.9% | +$551.20M | ||
| 2023 | $5.58B | +11.1% | +$559.50M | ||
| 2022 | $5.02B | +7.0% | +$329.70M | ||
| 2021 | $4.69B | -4.0% | −$193.90M | ||
| 2020 | $4.88B | +0.3% | +$15.60M | ||
| 2019 | $4.87B | +13.0% | +$558.60M | ||
| 2018 | $4.31B | +18.2% | +$664.70M | ||
| 2017 | $3.64B | +1.4% | +$49.50M | ||
| 2016 | $3.60B | +8.1% | +$268.40M | ||
| 2015 | $3.33B | +6.9% | +$214.30M | ||
| 2014 | $3.11B | +6.0% | +$176.20M | ||
| 2013 | $2.94B | +0.7% | +$21.70M | ||
| 2012 | $2.91B | -11.2% | −$366.00M | ||
| 2011 | $3.28B | +9.2% | +$276.90M | ||
| 2010 | $3.00B | +15.0% | +$390.90M | ||
| 2009 | $2.61B | +2.0% | +$51.80M | ||
| 2008 | $2.56B | +45.8% | +$804.90M | ||
| 2007 | $1.76B | +61.1% | +$666.15M | ||
| 2006 | $1.09B | +22.5% | +$200.18M | ||
| 2005 | $889.77M | +23.3% | +$168.21M | ||
| 2004 | $721.55M | +34.6% | +$185.51M | ||
| 2003 | $536.04M | +14.3% | +$66.96M | ||
| 2002 | $469.08M | +18.3% | +$72.45M | ||
| 2001 | $396.63M | +75.1% | +$170.08M | ||
| 2000 | $226.55M | — | — |
- 2025$6.52B+6.4%
- 2024$6.13B+9.9%
- 2023$5.58B+11.1%
- 2022$5.02B+7.0%
- 2021$4.69B-4.0%
- 2020$4.88B+0.3%
- 2019$4.87B+13.0%
- 2018$4.31B+18.2%
- 2017$3.64B+1.4%
- 2016$3.60B+8.1%
- 2015$3.33B+6.9%
- 2014$3.11B+6.0%
- 2013$2.94B+0.7%
- 2012$2.91B-11.2%
- 2011$3.28B+9.2%
- 2010$3.00B+15.0%
- 2009$2.61B+2.0%
- 2008$2.56B+45.8%
- 2007$1.76B+61.1%
- 2006$1.09B+22.5%
- 2005$889.77M+23.3%
- 2004$721.55M+34.6%
- 2003$536.04M+14.3%
- 2002$469.08M+18.3%
- 2001$396.63M+75.1%
- 2000$226.55M—
Revenue values are taken from CME Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at CME Group (CME)
According to CME Group's latest reported financial statements, the company's current revenue (TTM) is $6.76B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, CME Group (CME) reported revenue of $6.52B – grew 6.4% year-over-year.
Across 2020–2025 (5 years), CME Group revenue produced a CAGR of +6.0% – sustaining 4 straight years of year-over-year growth.
2025 marks the peak revenue at $6.52B, with the historical low of $226.55M recorded in 2000.
CME Group Revenue by Year
CME Group Revenue 2025: $6.52B
2025's revenue for CME Group came in at $6.52B, grew 6.4% from 2024. This figure represents the highest annual value in the available history.
CME Group Revenue 2024: $6.13B
CME Group posted revenue of $6.13B in 2024, grew 9.9% from 2023.
CME Group Revenue 2023: $5.58B
In 2023, CME Group reported revenue of $5.58B, grew 11.1% from 2022.
CME Group Revenue 2022: $5.02B
CME Group revenue in 2022 was $5.02B, grew 7.0% from 2021.
CME Group Revenue 2021: $4.69B
CME Group revenue in 2021 was $4.69B.
See more financial history for CME Group (CME).
Sector peers by Revenue
Financial Services peers of CME Group (CME), ranked by their latest revenue
| $371.44B | |
| $279.75B | |
| $191.57B | |
| $125.10B | |
| $123.53B | |
| $114.98B | |
| $40.00B | |
| $32.79B |
- $371.44B
- $279.75B
- $191.57B
- $125.10B
- $123.53B
- $114.98B
- $40.00B
- $32.79B
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation